Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells

Experimental and Molecular Medicine

Volumn 39, Issue 4, 2007, Pages 469-476

  Eun, Jeong Lee ^a   Eun, Mi Choi ^a   So, Ra Kim ^a   Jung, Hea Park ^a   Hyunsook, Kim ^b   Kwon, Soo Ha ^a   Young, Myeong Kim ^a   Sung, Soo Kim ^a   Choe, Myeon ^b   Kim, Jong Il ^c   Han, Jeong A ^a  

^a Kangwon National University College of Medicine   (South Korea)

^b Kangwon National University   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

Cell movement; Cell proliferation; Cyclooxygenase 2; Matrix metalloproteinases; Osteosarcoma

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2;

ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOSARCOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 34548821872     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2007.51     Document Type: Article

References (22)

1. s-axin-β-catenin signaling axis. Sience 2005;310:1504-10
2. Chen Q, Shinohara N, Abe T, Watanabe T, Nonomura K, Koyanagi T. Significance of COX-2 expression in human renal cell carcinoma cell lines. Int J Cancer 2004;108:825-32
3. Davies KJ. The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 1999;48:41-7
4. Dickens DS, Kozielski R, Khan J, Forus A, Cripe TP. Cyclooxygenase-2 expression in pediatric sarcomas. Pediatr Dev Pathol 2002;5:356-64
5. Dickens DS, Kozielski R, Leavey PJ, Timmons C, Cripe TP, Cyclooxygenase-2 expression does not correlate with outcome in osteosarcoma or rhabdomyosarcoma. J Pediatr Hematol Oncol 2003;25:282-5
6. Fujita H, Koshida K, Keller ET, Takahashi Y, Yoshimito T, Namiki M, Mizokami A. Cyclooxygenase-2 promotes prostate cancer progression. Prostate 2002;53:232-40
7. 1 receptor-mediated activation of the epidermal growth factor receptor and Akt. J Biol Chem 2005;280:24053-63
8. Klein G, Vellenga E, Fraaije MW, Kamps WA, de Bont ESJM. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol 2004;50:87-100
9. Klein RD, Pelt CSV, Sabichi AL, Cerda JD, Fischer SM, Furstenberger G, Muller-Decker K. Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression. Cancer Res 2005;65:1808-13
10. 2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res 2005;65:6275-81
11. Larkins TL, Nowell M, Singh S, Sanford GL. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 2006;181:1-12
12. Li G, Yang T, Yan J. Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells. Biochem Biophys Res Commun 2002;299:886-90
13. Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, Haudenschild C, Lane TF, Hla T. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 2001;276:18563-9
14. Longhi A, Errani C, de Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 2006;32:423-36
15. Naruse T, Nishida Y, Hosono K, Ishiguro N. Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes. Carcinogenesis 2006;27:584-92
16. Sanbino MA, Ghilardi JR, Jongen JL, Keyser CP, Luger NM, Mach DB, Peters CB, Rogers SD, Schwei MJ, de Felipe C, Mantyh PW. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Res 2002;62:7343-9
17. 2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 2001;276:18075-81
18. Singh B, Berry JA, Shoher A, Ramakrishnan V, Lucci A. COX-2 overexpression increases motility and invasion of breast cancer cells. Int J Oncol 2005;26:1393-9
19. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996;271:33157-60
20. Tsujii M, Kawano S, DuBois RN, Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997;94:3336-40
21. Xu Z, Choudhary S, Voznesensky O, Mehrotra M, Woodard M, Hansen M, Herschman H, Pilbeam C. Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis. Cancer Res 2006;66:6657-64
22. Yoon SO, Yun CH, Chung AS. Dose effect of oxidative stress on signal transduction on aging. Mech Ageing Dev 2002;123:1597-604